Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance

Br J Dermatol. 2019 Apr;180(4):949. doi: 10.1111/bjd.17423. Epub 2019 Jan 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents
  • Clindamycin*
  • Drug Therapy, Combination
  • Hidradenitis Suppurativa*
  • Humans
  • Rifampin

Substances

  • Anti-Bacterial Agents
  • Clindamycin
  • Rifampin